نتایج جستجو برای: blocking antibodies

تعداد نتایج: 206867  

2016
Peleg Rider Yaron Carmi Idan Cohen

Proinflammatory cytokines are potent mediators of numerous biological processes and are tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and derive many pathologies, including incidences of autoimmunity and cancer. Therefore, therapies that regulate the activity of inflammatory cytokines, either by supplementation of anti-inflammatory recombinant cytokin...

Journal: :The Journal of Experimental Medicine 1986
P A Rice H E Vayo M R Tam M S Blake

Neisseria gonorrhoeae that resist complement-dependent killing by normal human serum (NHS) are sometimes killed by immune convalescent serum from patients recovering from disseminated gonococcal infection (DGI). In these studies, killing by immune serum was prevented or blocked by IgG isolated from NHS. Purified human IgG antibodies directed against gonococcal protein III, an antigenically cons...

Journal: :Japanese journal of infectious diseases 2012
Natda Tonwong Jetsumon Sattabongkot Takafumi Tsuboi Hideyuki Iriko Satoru Takeo Jeeraphat Sirichaisinthop Rachanee Udomsangpetch

We identified naturally induced antibodies from malaria patients in Thailand and clarified the effect of the antibodies on gametocyte development. Fifty-nine percent of the Plasmodium falciparum-infected blood samples (17 of 29) fed to female Anopheles mosquitoes showed no oocyst infection. Seventeen percent of the samples (5 of 29) distorted the morphology and hampered the maturity of the ...

Journal: :Cell 2010
Mark P. Chao Ash A. Alizadeh Chad Tang June H. Myklebust Bindu Varghese Saar Gill Max Jan Adriel C. Cha Charles K. Chan Brent T. Tan Christopher Y. Park Feifei Zhao Holbrook E. Kohrt Raquel Malumbres Javier Briones Randy D. Gascoyne Izidore S. Lossos Ronald Levy Irving L. Weissman Ravindra Majeti

Monoclonal antibodies are standard therapeutics for several cancers including the anti-CD20 antibody rituximab for B cell non-Hodgkin lymphoma (NHL). Rituximab and other antibodies are not curative and must be combined with cytotoxic chemotherapy for clinical benefit. Here we report the eradication of human NHL solely with a monoclonal antibody therapy combining rituximab with a blocking anti-C...

2012
Tanja Holopainen Pipsa Saharinen Gabriela D’Amico Anita Lampinen Lauri Eklund Raija Sormunen Andrey Anisimov Georgia Zarkada Marja Lohela Hanna Heloterä Tuomas Tammela Laura E. Benjamin Seppo Ylä-Herttuala Ching Ching Leow Gou Young Koh Kari Alitalo

BACKGROUND Angiopoietin-2 (Ang2), a ligand for endothelial TEK (Tie2) tyrosine kinase receptor, is induced in hypoxic endothelial cells of tumors, where it promotes tumor angiogenesis and growth. However, the effects of Ang2 on tumor lymphangiogenesis and metastasis are poorly characterized. METHODS We addressed the effect of Ang2 on tumor progression and metastasis using systemic Ang2 overex...

2009
J. C. CRUICKSHANK

It was shown by Wiener (1944) that some human a,nti-Rh sera contained incomplete antibodies which combined with but did not agglutinate the corresponding red cells. They appeared to be more avid than agglutinating antibodies, so that, if the two kinds of antibody co-existed in the same serum, the incomplete or blocking antibody might account for failure of agglutination or for a zone of inhibit...

Journal: :The Journal of Cell Biology 1986
E Engvall G E Davis K Dickerson E Ruoslahti S Varon M Manthorpe

Monoclonal antibodies were made against a truncated form of human laminin isolated from placenta. 12 antibodies were isolated and characterized. All antibodies stained basement membranes in placenta and immunoprecipitated laminin from media of cultured choriocarcinoma cells. Three antibodies, 3E5, 4C7, and 4E10, partially blocked the neurite-promoting activity of laminin. Addition of a second a...

Journal: :Clinical chemistry 2010
Thomas R Haven Mark E Astill Brian M Pasi James B Carper Lily L Wu Anne E Tebo Harry R Hill

Myasthenia gravis (MG) is a wellcharacterized autoimmune disease with an estimated prevalence of 1 in 5000 individuals (1 ). The clinical presentation varies from mild weakness of limited muscle groups (class I or ocular MG) to severe weakness of multiple muscle groups (class V or severe generalized MG). Detection of autoantibodies to the neuromuscular nicotinic acetylcholine receptor (ACHR) ha...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید